Probability of complete cytogenetic response and molecular remission after CD4⁺ DLI in patients with relapsed early-phase CML. Nineteen patients with cytogenetic or stable-phase CML relapse were evaluable for response. Three nonresponders received second infusions of CD4⁺ donor lymphocytes and were censored at the time of second infusion.